Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials (Q43194317)
Jump to navigation
Jump to search
scientific article published on 12 January 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials |
scientific article published on 12 January 2010 |
Statements
1 reference
Switch to a raltegravir-based regimen versus continuation of a lopinavir-ritonavir-based regimen in stable HIV-infected patients with suppressed viraemia (SWITCHMRK 1 and 2): two multicentre, double-blind, randomised controlled trials (English)
1 reference
Gerd Fätkenheuer
1 reference
Joseph J Eron
1 reference
Benjamin Young
1 reference
David A Cooper
1 reference
Michael Youle
1 reference
Edwin Dejesus
1 reference
Jaime Andrade-Villanueva
1 reference
Cassy Workman
1 reference
Roberto Zajdenverg
1 reference
Daniel S Berger
1 reference
Princy N Kumar
1 reference
Anthony J Rodgers
1 reference
Melissa A Shaughnessy
1 reference
Monica L Walker
1 reference
Richard J O Barnard
1 reference
Michael D Miller
1 reference
Mark J Dinubile
1 reference
Bach-Yen Nguyen
1 reference
Randi Leavitt
1 reference
Xia Xu
1 reference
Peter Sklar
1 reference
SWITCHMRK 1 and 2 investigators
1 reference
12 January 2010
1 reference
1 reference
Identifiers
1 reference